What information about diffuse parenchymal lung diseases (DPLDs) should patients be given?

Updated: Sep 15, 2020
  • Author: Eleanor M Summerhill, MD, FACP, FCCP; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
  • Print
Answer

Educate patients about the nature of the specific diagnosis and about potential toxicities of prescribed medications.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!